Table 2.
Metabolite | Premature infants <36 weeks (n = 24) | Term newborns >36 weeks (n = 75) | Children <5 years (n = 880) | Subjects 5–18 years (n = 511) | Adults (n = 60) |
---|---|---|---|---|---|
Isovalerylglutamic acid | n.d. | n.d. | n.d. | n.d. | n.d. |
3-OH-propionic acid | 4.21; 1–6 | 4.26; 0–11 | 4.65; 0–13 | 3.66; 0–11 | 2.19; 0–5 |
Tiglylglycine | n.d. | 0.11; 0–1 | 0.30; 0–2 | 0.01; 0–2 | 0.01; 0–1 |
2-OH-isovaleric acid | 1.00; 0–4 | 0.01; 0–0.41 | 0.01; 0–1 | 0.01; 0–3 | 0.01; 0–2 |
3-OH-isovaleric acid | 0.68; 0–10 | 0.23; 0–4 | 2.00; 0–11 | 1.00; 0–8 | 0.01; 0–3 |
Methylmalonic acid | n.d. | 2.00; 0–5 | 1.29; 0–5 | 1.00; 0–3 | 0.01; 0–2 |
Propionylglycine | n.d. | n.d. | n.d. | n.d. | n.d. |
Isovalerylglycine | n.d. | n.d. | 0.15; 0–1 | 0.01; 0–1 | n.d. |
2-keto-isovaleric acid | n.d. | n.d. | 0.01; 0–0 | 0.01; 0–0 | n.d. |
2-keto-3-Me-valeric acid | n.d. | 0.03; 0–1 | 0.04; 0–1 | 0.11; 0–2 | 0.01; 0–1 |
2-keto-isocaproic acid | n.d. | 0.17; 0–1 | 0.20; 0–1 | 0.13; 0–1 | 0.1; 0–1 |
2-OH-isocaproic acid | n.d. | n.d. | n.d. | n.d. | n.d. |
2-OH-3-Me-valeric acid | n.d. | n.d. | n.d. | n.d. | n.d. |
2-Methylcitric acid | n.d. | n.d. | 0.02; 0–0 | 0.01; 0–0 | 0.01; 0–0 |
Metabolites are quantified as mmol/mol creatinine. n.d., not detectable.